Match Document Document Title
US20110312911 GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE  
Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also...
US20140377150 SCANDIUM EXTRACTION METHOD  
Provided is a method for selectively extracting and inexpensively recovering scandium from an acidic solution containing calcium, magnesium, and scandium. The scandium extraction method according...
US20150087680 GLUCAGON ANTAGONISTS  
Provided herein are compounds, including enantiomerically pure forms thereof, and pharmaceutically acceptable salts or co-crystals and prodrugs thereof which have glucagon receptor antagonist or...
US20140031587 SUCCINIC ACID PRODUCTION IN A EUKARYOTIC CELL  
The present invention relates to a recombinant eukaryotic cell selected from a yeast of a filamentous fungus comprising a nucleotide sequence encoding a NAD(H)-dependent fumarate reductase that...
US20120165569 SUCCINIC ACID PRODUCTION IN A EUKARYOTIC CELL  
The present invention relates to a recombinant eukaryotic cell selected from a yeast of a filamentous fungus comprising a nucleotide sequence encoding a NAD(H)-dependent fumarate reductase that...
US20090162420 Matrix-Controlled Transdermal System Comprising Salts of ACE Inhibitor Dicarboxylic Acids  
The invention relates to a salt of an ACE inhibitor dicarboxylic acid with an organic amine and/or an alkali compound, a transdermal therapeutic system comprising the salt, and a method of...
US20130217909 PROCESS FOR OBTAINING ACROLEIN BY CATALYTIC DEHYDRATION OF GLYCEROL OR GLYCERIN  
A continuous process for obtaining acrolein by catalytic dehydration of glycerol or glycerin, in the presence of an acid catalyst, wherein said process comprises the concomitant regeneration of...
US20130079553 CATALYSTS FOR PRODUCING ACRYLIC ACIDS AND ACRYLATES  
In one embodiment, the invention is to a catalyst composition comprising vanadium and titanium. The catalyst composition has a surface area of at least 22.6 m2/g and a plurality of pores, and the...
US20050113606 Continuous production of chlorodifluoroacetyl fluoride via chlorotrifluoroethylene oxidation  
The invention pertains to a process for preparing chlorodifluoroacetyl fluoride (CDAF) by oxidation of chlorotrifluoroethylene (CTFE) in a solvent using a continuously stirred tank reactor. It...
US20130211116 SALTS OF 5-SULFOISOPHTHALIC ACID AND METHOD OF MAKING SAME  
This invention relates to methods for the production of various metal salts of 5-sulfoisophthalic acid including those where the metal cation is selected from the group consisting of silver (I),...
US20140018571 Eductor-Based Reactor and High Flow Pump Around Loops for Production of Acetic Acid  
Eductor mixers are used to mix the reaction medium in a carbonylation reactor. A portion of the reaction solution withdrawn from the reactor and directed through a pump around loop. The pump...
US20130338229 Abuse-Deterrent Methadone for the Safe Treatment of Drug Abuse and Pain Relief  
Provided is a drug substance and a method of treating an ailment comprising administering an oral dose of a drug product comprising the drug substance wherein the drug substance comprises an...
US20130211137 DIRECT ACTIVATION OF METHANE  
Heteropolyacids (HPAs) can activate methane at ambient temperature (e.g., 20° C.) and atmospheric pressure, and transform methane to acetic acid, in the absence of any noble metal such as Pd). The...
US20100297715 METHOD FOR PRODUCING SUCCINIC ACID  
The invention relates to methods for producing succinic acid and/or succinate ions by fermentation under anaerobic conditions.
US20130090314 SOLID STATE FORMS OF TAPENTADOL SALTS  
Provided herein are novel solid state forms of tapentadol salts, process for their preparation, pharmaceutical compositions, and method of treating thereof. The tapentadol salts include an...
US20110071120 SOLID STATE FORMS OF TAPENTADOL SALTS  
Provided herein are novel solid state forms of tapentadol salts, process for their preparation, pharmaceutical compositions, and method of treating thereof. The tapentadol salts include an...
US20110207036 Electrophoretic Particle Salt For Electrophoretic Display And Method Of Making  
An electrophoretic particle salt that includes a cationic electrophoretic particle and an anionic group ionically associated with the cationic electrophoretic particle is employed in an...
US20060217533 Production of N-acyl compounds  
A process for producing a compound containing an acylated nitrogen atom in which the adduct compound formed from an N-protonated cation and a chloride, bromide or iodide anion or the free nitrogen...
US20110151025 Compositions Comprising N-Halogenated or N,N-Dihalogenated Amine for Treatment and Prophylaxis of Bronchopulmonary Infections  
Disclosed herein are methods and compositions for the treatment or prophylaxis, in a mammal, of bronchopulmonary infections, obstructive pulmonary disease, cystic fibrosis, and...
US20140031546 HYDRODEOXYGENATION CATALYST  
A hydrodeoxygenation catalyst comprises a metal catalyst, an acid promoter, and a support. The metal catalyst is selected from platinum, palladium, ruthenium, rhenium rhodium, osmium, iridium,...
US20140288210 RESIN COMPOSITION, RESIN MOLDED ARTICLE, AND SURFACE-TREATED RED PHOSPHORUS  
A resin composition includes a resin selected from a polylactic acid resin and a polycarbonate resin as a matrix resin, and surface-treated red phosphorus, wherein the surface-treated red...
US20110190302 Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use  
The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-phenylene compounds of the following formula (I)...
US20090203706 LYSINE-BASED POLYMERIC LINKERS  
The present invention provides polymeric linkers containing branching moieties. Methods of making the polymeric linkers and methods of making conjugates using the same are also disclosed.
US20080299089 ENDOGENEOUS REPAIR FACTOR PRODUCTION PROMOTERS  
It relates to an endogenous repair factor production accelerator which comprises one or at least two selected from prostaglandin (PG) 12 agonist, EP2 agonist and EP4 agonist. Since prostaglandin...
US20120065409 METHODS OF MAKING LUBIPROSTONE AND INTERMEDIATES THEREOF  
There is provided processes for preparing Lubiprostone and intermediates thereof. Also provided are compounds, including intermediates for preparing Lubiprostone as well compositions comprising...
US20100170395 Tetratopic Phenyl Compounds, Related Metal-Organic Framework Materials and Post-Assembly Elaboration  
Disclosed are tetratopic carboxylic acid phenyl for use in metal-organic framework compounds. These compounds are useful in catalysis, gas storage, sensing, biological imaging, drug delivery and...
US20140187817 PREPARATION OF METHACRYLIC ACID  
The invention relates to a process for preparation of methacrylic acid, comprising process steps a) providing a crude methacrylic acid-comprising aqueous solution comprising at least one impurity...
US20060270863 CONVERSION OF AMORPHA-4,11-DIENE TO ARTEMISININ AND ARTEMISININ PRECURSORS  
The present invention relates to methods for the conversion of amorpha-4,11-diene to artemisinin and various artemisinin precursors.
US20120074354 METHOD FOR THE RESTABILIZATION OF (METH)ACRYLIC MONOMERS  
A process for replacing the stabilization of (meth)acrylic monomers, wherein phenothiazine is removed from phenothiazine-containing (meth)acrylic monomers by adsorption on activated carbon, and...
US20110038804 MR IMAGING AGENT, IMAGING MEDIUM AND METHODS OF IMAGING WHEREIN SUCH AN IMAGING MEDIUM IS USED  
The invention relates to hyperpolarised 13C-α-ketoisocaproate, its use as imaging agent, an imaging medium comprising hyperpolarised 13C-α-ketoisocaproate and methods of 13C-MR detection wherein...
US20120004308 METHOD FOR OBTAINING SOLID MICRO- OR NANOPARTICLES  
The invention provides a novel method for obtaining solid micro- or nanoparticles with a homogeneous structure. A method is provided for obtaining solid micro- or nanoparticles with a homogeneous...
US20140086837 F-18 RADIOLABELED COMPOUNDS FOR DIAGNOSING AND MONITORING KIDNEY FUNCTION  
The invention relates to 18F-labeled compounds of formula (I), hydrates, isomers, or pharmaceutically acceptable salts thereof, process for their preparation and pharmaceutical compositions. The...
US20120016160 Solvent-Free Preparation Of Magnesium Formate-Based Porous Metal-Organic Framework  
The present invention relates to a process for preparing a magnesium formate-based porous metal-organic framework, which comprises the steps (a) addition of magnesium or magnesium oxide to formic...
US20120252708 COATED PARTICLES OF A GLUTAMIC ACID N,N-DIACETATE CHELATING AGENT  
Process to prepare coated particles containing a particle and a coating, wherein the particle contains glutamic acid N,N-diacetic acid or a (partial) salt thereof of the formula HnYm-GLDA, wherein...
US20120028977 Subunit Selective NMDA Receptor Potentiators For The Treatment Of Neurological Conditions  
Provided are compounds, pharmaceutical compositions and methods of treating or preventing disorders associated with NMDA receptor activity, including schizophrenia, Parkinson's disease, cognitive...
US20120010426 Processes Related to the Hydroformylation of Butenes  
Mixed butene streams containing butene-1 and isobutylene and optionally butene-2 are hydroformylated under conditions that hydroformylates all the monomers to yield a mixture of valeraldehydes
US20110137071 Processes Related To The Hydroformylation Of Butenes  
Mixed butene streams containing butene-1 and isobutylene and optionally butene-2 are hydroformylated under conditions that hydroformylates all the monomers to yield a mixture of valeraldehydes
US20110077298 Retinoid Derivative and Pharmaceutical Composition and Use Thereof  
The invention relates to a retinoid derivative and pharmaceutical composition and use thereof. The compound of the invention is capable of preventing or treating hematological tumours, such as...
US20140296566 Simplified Radiosynthesis of O-[18F]Fluoromethyl Tyrosine Derivatives  
This invention relates to the simplified radiosynthesis of O-[18F]fluoromethyl tyrosine derivatives whereby the need for purification by preparative high pressure liquid chromatographic methods...
US20110287436 Detection Of Analytes And Nucleic Acids  
Methods of detecting at least one analyte and at least one nucleic acid in a sample are provided. Reagents for carrying out the methods are also provided.
US20070167653 Method for producing acylphosphine oxide solids  
The present invention relates to a process for the preparation of solid acylphosphine oxides by converting an acylphosphine oxide which is in the form of a melt or in dispersed form into the solid...
US20120040422 DICARBOXYLIC ACID PRODUCTION PROCESS  
The present invention relates to a process for the production of a dicarboxylic acid and ethanol which comprises fermenting a genetically modified yeast in a suitable fermentation medium under...
US20110015290 USE OF METAL SALTS OF A CARBOXYLIC ACID IN THE PRODUCTION OF POLYURETHANE SYSTEMS  
A catalyst system which is suitable for catalyzing the production of polyurethane systems is provided. The catalyst system contains a metal salt of a carboxylic acid to whose carbonyl carbon a...
US20090012093 Receptor Function Regulator  
The GPR40 receptor function regulator of the present invention, which comprises a compound having an aromatic ring and a group capable of releasing cation is useful as an insulin secretagogue or...
US20110028675 CYCLOHEXANONE PRODUCTION PROCESS WITH MULTIPLE POST-DISTILLATION  
The present invention relates to a method for continuously preparing cyclohexanone from phenol making use of a catalyst comprising at least one catalytically active metal selected from platinum...
US20100076080 Synthesis of Cyclohexane Derivatives Useful as Sensates in Consumer Products  
The present invention provides synthetic routes for preparing various isomers of cyclohexane-based coolants, such as menthyl esters and menthanecarboxamide derivatives, in particular those...
US20150239918 FUNCTIONALIZED CARBON MATRIX MATERIALS  
Various embodiments of the present invention provide a functionalized carbon matrix, compositions and composites including the same, and methods of making and using the same. In various...
US20130331603 Process for Purifying Terephthalic Acid Using Ionic Liquids  
Methods of purifying crude or contaminated terephthalic acid using ionic liquids are described. Crude or contaminated terephthalic acid is contacted with a solvent in the absence of an oxidizing...
US20150164754 ANTI-AGEING COMPOSITION CONTAINING DEHYDROGENATED ABIETIC ACID AS ACTIVE INGREDIENT  
An objective of the present invention is to provide a skin ageing preventing composition that contains dehydrogenated abietic acid as an active ingredient and consequently has an outstanding...
US20080138309 Use Of Aminodithiol As A Reducing Agent For Hair Perming  
The present invention relates to the use of aminodithiols as reducing agents for hair perming. It further relates to a hair perming method using these aminodithiols.